Ukr.Biochem.J. 2024; Volume 96, Issue 5, Sep-Oct, pp. 31-37

doi: https://doi.org/10.15407/ubj96.05.031

Osteopontin as a biomarker for diagnosing the severity of osteoarthritis

16.10.2024   Uncategorized   No comments

M. A. Taha, Z. M. A. A. Hamodat*

Department of Chemistry, College of Science, University of Mosul, Iraq;
*e-mail: zahraahamodat@uomosul.edu.iq

Received: 25 April 2024; Revised: 30 August 2024;
Accepted: 07 October 2024; Available on-line: 28 October 2024

Osteoarthritis (OA) is the most common type of arthritis. It is characterized by the loss of cartilage and pain ultimately leading to difficulty in movement. Glycoprotein osteopontin (OPN) is an essential regulator that plays a critical role in developing osteoarthritis. The study aims to determine the level of OPN in the serum of patients with OA and its correlation with the content of calcium (Ca), phosphorus (P), and magnesium (Mg). The study was conducted on 92 male and female patients aged between 30 and 65, categorized into mild, moderate, and severe groups through clinical examination and X-rays. The control group consist of 58 healthy males and females 30-65-year old. OPN was measured using the ELISA technique, and minerals were estimated using spectrophotometry. It was shown that in OA patients, OPN level increased highly significant when compared with the control group (10.7 ± 3.4 ng/ml) and depended on OA severity. In patients with severe OA, it was higher (47.5 ± 8.1 ng/ml) than in groups with moderate (14.8 ± 4.5 ng/ml) and mild (12.1 ± 3.1 ng/ml) extent of the disease. We showed a significant positive relationship between OPN and phosphorus levels and a negative significant correlation between OPN and calcium, calcium/phosphorus ratio, and magnesium. These findings underscore the potential of OPN as a valuable biomarker for diagnosing the severity of osteoarthritis and monitoring the effectiveness of treatment.

Keywords: , , , ,

References:

  1. Karimi SB, Awalkhail F, Walizada S. Knee osteoarthritis: Assesment of quality of life in these patients. Sci Educ. 2024;5(3):105-110.‏
  2. Cao Y, Winzenberg T, Nguo K, Lin J, Jones G, Ding C. Association between serum levels of 25-hydroxyvitamin D and osteoarthritis: a systematic review. Rheumatology (Oxford). 2013;52(7):1323-1334. PubMed, CrossRef
  3. Mermerci Başkan B, Yurdakul FG, Aydın E, Sivas F, Bodur H. Effect of vitamin D levels on radiographic knee osteoarthritis and functional status. Turk J Phys Med Rehabil. 2017;64(1):1-7. PubMed, PubMedCentral, CrossRef
  4. Hamodat ZMA, Khaleel NF. Study on some biochemical markers for women affected with joint disease. Biochem Cell Arch. 2020;20(2):553-5543.
  5. Sur D, Chakravorty R. Relationship of thyroid and sex hormones with osteoarthritis in postmenopausal Indian women. J Clin Gynecol Obstet. 2016;5(4): 117-120. CrossRef
  6. Hamodat ZMA, Al-Ashou LKO. Study of cartilage oligomeric matrix protein (COMP) level in serum and synovial fluid for osteoarthritis patients and its relationship level of vitamin D, parathyroid hormone and disease severity. Biochem Cell Arch. 2021; 21(suppl 1):2111-2122.
  7. Sharma AR, Jagga S, Lee SS, Nam JS. Interplay between cartilage and subchondral bone contributing to pathogenesis of osteoarthritis. Int J Mol Sci. 2013;14(10):19805-19830. PubMed, PubMedCentral, CrossRef
  8. Salvo SG. Musculoskeletal Pathologies, Disorders, and Injuries. Mosby’s Pathology for Massage Professionals – E-Book: Mosby’s Pathology for Massage Professionals – E-Book. 5th Edition. 2021. 544 p.‏
  9. Jang S, Lee K, Ju JH. Recent Updates of Diagnosis, Pathophysiology, and Treatment on Osteoarthritis of the Knee. Int J Mol Sci. 2021;22(5):2619. PubMed, PubMedCentral, CrossRef
  10. Wallace IJ, Worthington S, Felson DT, Jurmain RD, Wren KT, Maijanen H, Woods RJ, Lieberman DE. Knee osteoarthritis has doubled in prevalence since the mid-20th century. Proc Natl Acad Sci USA. 2017;114(35):9332-9336. PubMed, PubMedCentral, CrossRef
  11. Allen KD, Thoma LM, Golightly YM. Epidemiology of osteoarthritis. Osteoarthritis Cartilage. 2022;30(2):184-195. PubMed, PubMedCentral, CrossRef
  12. Litwic A, Edwards MH, Dennison EM, Cooper C. Epidemiology and burden of osteoarthritis. Br Med Bull. 2013;105:185-199. PubMed, PubMedCentral, CrossRef
  13. Godziuk K, Hawker GA. Obesity and body mass index: Past and future considerations in osteoarthritis research. Osteoarthritis Cartilage. 2024;32(4):452-459. PubMed, CrossRef
  14. Bastos ACSDF, Gomes AVP, Silva GR, Emerenciano M, Ferreira LB, Gimba ERP. The Intracellular and Secreted Sides of Osteopontin and Their Putative Physiopathological Roles. Int J Mol Sci. 2023;24(3):2942. PubMed, PubMedCentral, CrossRef
  15. Tan Y, Zhao L, Yang YG, Liu W. The Role of Osteopontin in Tumor Progression Through Tumor-Associated Macrophages. Front Oncol. 2022;12:953283. PubMed, PubMedCentral, CrossRef
  16. Kuzan A, Chwiłkowska A, Maksymowicz K, Abramczyk U, Gamian A. Relationships between Osteopontin, Osteoprotegerin, and Other Extracellular Matrix Proteins in Calcifying Arteries. Biomedicines. 2024;12(4):847. PubMed, PubMedCentral, CrossRef
  17. Bai RJ, Li YS, Zhang FJ. Osteopontin, a bridge links osteoarthritis and osteoporosis. Front Endocrinol (Lausanne). 2022;13:1012508. PubMed, PubMedCentral, CrossRef
  18. Martín-Márquez BT, Sandoval-García F, Corona-Meraz FI, Martínez-García EA, Sánchez-Hernández PE, Salazar-Páramo M, Fletes-Rayas AL, González-Inostroz D, Vazquez-Del Mercado M. Osteopontin: A Bone-Derived Protein Involved in Rheumatoid Arthritis and Osteoarthritis Immunopathology. Biomolecules. 2023;13(3):502. PubMed, PubMedCentral, CrossRef
  19. Hamodat ZMAA. Properties of alpha-L-fucosidase for serum of patients with hepatocellular cancer and cytotoxicity on some cancer cell lines. Ukr Biochem J. 2021;93(6):76-86. CrossRef
  20. Min S, Shi T, Han X, Chen D, Xu Z, Shi D, Teng H, Jiang Q. Serum levels of leptin, osteopontin, and sclerostin in patients with and without knee osteoarthritis. Clin Rheumatol. 2021;40(1):287-294. PubMed, CrossRef
  21. Kulkarni P, Srivastava V, Tootsi K, Electricwala A, Kharat A, Bhonde R, Koks S, Martson A, Harsulkar A. Synovial Fluid in Knee Osteoarthritis Extends Proinflammatory Niche for Macrophage Polarization. Cells. 2022;11(24):4115. PubMed, PubMedCentral, CrossRef
  22. Dai G, Xiao H, Liao J, Zhou N, Zhao C, Xu W, Xu W, Liang X, Huang W. Osteocyte TGFβ1‑Smad2/3 is positively associated with bone turnover parameters in subchondral bone of advanced osteoarthritis. Int J Mol Med. 2020;46(1):167-178. PubMed, PubMedCentral, CrossRef
  23. Jiang L, Tian W, Wang Y, Rong J, Bao C, Liu Y, Zhao Y, Wang C. Body mass index and susceptibility to knee osteoarthritis: a systematic review and meta-analysis. Joint Bone Spine. 2012;79(3):291-297. PubMed, CrossRef
  24. King LK, March L, Anandacoomarasamy A. Obesity & osteoarthritis. Indian J Med Res. 2013;138(2):185-193. PubMed, PubMedCentral
  25. Tudorachi NB, Eva I, Dascalu CG, Al-Hiary R, Barbieru B, Paunica M, Motofei C, Moraru AC. The influence of serum calcium and magnesium levels in the radiological evolution of knee osteoarthritis. J Mind Med Sci. 2020;7(2):217-226. CrossRef
  26. Qu Z, Yang F, Hong J, Wang W, Li S, Jiang G, Yan S. Causal relationship of serum nutritional factors with osteoarthritis: a Mendelian randomization study. Rheumatology (Oxford). 2021;60(5):2383-2390. PubMed, CrossRef
  27. Jakoniuk M, Kochanowicz J, Lankau A, Wilkiel M, Socha K. Concentration of Selected Macronutrients and Toxic Elements in the Blood in Relation to Pain Severity and Hydrogen Magnetic Resonance Spectroscopy in People with Osteoarthritis of the Spine. Int J Environ Res Public Health. 2022;19(18):11377. PubMed, PubMedCentral, CrossRef
  28. Ganguly A. Determination of the impact of functional instability of parathyroid hormone and the calcium-phosphorus ratio as risk factors during osteoarthritic disorders using receiver operating characteristic curves. Int Arch BioMed Clin Res. 2017;3(4):47-52. CrossRef
Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License.